Federal Funding of Vaccine Research
To secure a federal grant, researchers must navigate a rigorous and long application process. But, when completed properly, those projects deemed most likely to have an impact on the nation’s health do get funded.
New Monograph Published to Increase Tdap Vaccine Rates
A new monograph from The Joint Commission is intended to help healthcare organizations implement or enhance Tdap vaccination programs.
Adults Fall Short on Vaccinations
According to the Centers for Disease Control and Prevention, vaccination rates for adults are lower than they should be.
Canada Approves New Flu Vaccine for Seniors
Health Canada has approved Fluad, a seasonal flu vaccine manufactured by Novartis for adults aged 65 years and older. Fluad is the first seasonal flu vaccine in Canada to contain an adjuvant.
Vaccine Update
Updates on vaccines including herpes, hepatitis E, dengue fever, cervical cancer and more.
Vaccine May Fight Cancer and HIV
Researchers at the University of Oklahoma Health Sciences Center have found a way to create a vaccine using T cells that activate a distinct part of the immune system.
CDC Says Most U.S. Teens Get Vaccinated
According to the U.S. Centers for Disease Control and Prevention, more U.S. teens are getting recommended vaccines against certain cancers, meningitis and infectious diseases.
Vaccine Sales Growing
Global sales of vaccines grew in 2009, according to healthcare market research publisher Kalorama Information, and researchers are forecasting sales to rise at a compound annual rate during the next five years.
New Meningitis Vaccine Could Prevent Outbreaks
A new meningitis vaccine will help to prevent epidemics in Africa for the first time.
The New High-Dose Flu Vaccine: An Extra Boost for Seniors
New research comparing the new Fluzone High-Dose vaccine and the seasonal flu vaccine sheds light on how ineffective the latter vaccine has been for the elderly.